Briejer M R, Veen G J, Akkermans L M, Lefebvre R A, Schuurkes J A
Department of Gastrointestinal Pharmacology, Janssen Research Foundation, Beerse, Belgium.
J Pharmacol Exp Ther. 1995 Aug;274(2):641-8.
In the guinea pig proximal colon, 5-hydroxytryptamine (5-HT) stimulates neuronal 5-HT1-like receptors to induce relaxations that are mediated by nitric oxide and ATP. In the current study, the effects of cisapride and structural analogs on these 5-HT-induced relaxations were investigated. In the continuous presence of ketanserin (0.3 microM) and tropisetron (3 microM) to block contractions via 5-HT2A, 5-HT3 and 5-HT4 receptors, 5-HT induced relaxations that yielded a biphasic concentration-response curve. Cisapride (0.1-1 microM) enhanced the second phase of the concentration-response curve to 5-HT by about 20% to 40%, whereas from 0.3 microM onwards, it inhibited the first phase. Also in the presence of cisapride (0.3 microM), tetrodotoxin (0.3 microM) abolished the relaxations to 5-HT. Cisapride (0.3 microM) did not affect the concentration-response curves to isoprenaline, nitroglycerin, nitroprusside or exogenous ATP, which demonstrated its specificity. The 5-HT relaxation-enhancing effects of cisapride were not mimicked by phentolamine (1 microM), NAN-190 (0.03 microM), spiperone (1 microM), citalopram (0.3 microM), paroxetine (0.3 microM), pargyline (100 microM) or SDZ 205-557 (0.3 microM). In the presence of the inhibitor of nitric oxide synthesis, NG-nitro-L-arginine (100 microM), cisapride (0.3 microM) still enhanced the remaining relaxations to 5-HT (2-3-fold). However, in the presence of the P2-purinoceptor antagonist suramin (300 microM), cisapride did not enhance the relaxations to 5-HT. In the presence of NG-nitro-L-arginine, the cisapride-enhanced relaxations to 5-HT were inhibited by about 90% by suramin. We conclude that in the guinea pig colon, cisapride selectively facilitates the suramin-sensitive, ATP-mediated part of the relaxation to 5-HT via an unidentified effect on intramural nerves.
在豚鼠近端结肠中,5-羟色胺(5-HT)刺激神经元5-HT1样受体以诱导由一氧化氮和ATP介导的舒张。在本研究中,研究了西沙必利及其结构类似物对这些5-HT诱导的舒张的影响。在持续存在酮色林(0.3微摩尔)和托烷司琼(3微摩尔)以通过5-HT2A、5-HT3和5-HT4受体阻断收缩的情况下,5-HT诱导的舒张产生了双相浓度-反应曲线。西沙必利(0.1-1微摩尔)使5-HT浓度-反应曲线的第二阶段增强约20%至40%,而从0.3微摩尔起,它抑制第一阶段。同样在存在西沙必利(0.3微摩尔)的情况下,河豚毒素(0.3微摩尔)消除了对5-HT的舒张反应。西沙必利(0.3微摩尔)不影响对异丙肾上腺素、硝酸甘油、硝普钠或外源性ATP的浓度-反应曲线,这证明了其特异性。酚妥拉明(1微摩尔)、NAN-190(0.03微摩尔)、螺哌隆(1微摩尔)、西酞普兰(0.3微摩尔)、帕罗西汀(0.3微摩尔)、帕吉林(100微摩尔)或SDZ 205-557(0.3微摩尔)均未模拟西沙必利对5-HT舒张增强的作用。在一氧化氮合成抑制剂NG-硝基-L-精氨酸(100微摩尔)存在的情况下,西沙必利(0.3微摩尔)仍使对5-HT的剩余舒张增强(2-3倍)。然而,在P2-嘌呤受体拮抗剂苏拉明(300微摩尔)存在的情况下,西沙必利并未增强对5-HT的舒张作用。在存在NG-硝基-L-精氨酸的情况下,苏拉明使西沙必利增强的对5-HT的舒张作用受到约90%的抑制。我们得出结论,在豚鼠结肠中,西沙必利通过对壁内神经的未知作用选择性地促进了对5-HT舒张中苏拉明敏感、ATP介导的部分。